Drug Information

Drug General Information
Drug ID
D06UIS
Former ID
DIB010621
Drug Name
LY-2828360
Indication Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] Phase 2 [523404]
Company
Eli Lilly & Co
Target and Pathway
Target(s) Cannabinoid receptor 2 Target Info Agonist [551579]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 523404ClinicalTrials.gov (NCT01319929) A Study of LY2828360 in Patients With Osteoarthritic Knee Pain. U.S. National Institutes of Health.
Ref 551579Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands. Current Medicinal Chemistry . 10/2013; 21(2).

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.